Literature DB >> 19605939

Physiology and pharmacology of melatonin in relation to biological rhythms.

Jolanta B Zawilska1, Debra J Skene, Josephine Arendt.   

Abstract

Melatonin is an evolutionarily conserved molecule that serves a time-keeping function in various species. In vertebrates, melatonin is produced predominantly by the pineal gland with a marked circadian rhythm that is governed by the central circadian pacemaker (biological clock) in the suprachiasmatic nuclei of the hypothalamus. High levels of melatonin are normally found at night, and low levels are seen during daylight hours. As a consequence, melatonin has been called the "darkness hormone". This review surveys the current state of knowledge regarding the regulation of melatonin synthesis, receptor expression, and function. In particular, it addresses the physiological, pathological, and therapeutic aspects of melatonin in humans, with an emphasis on biological rhythms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19605939     DOI: 10.1016/s1734-1140(09)70081-7

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  66 in total

Review 1.  Circadian disruption and remedial interventions: effects and interventions for jet lag for athletic peak performance.

Authors:  Sarah Forbes-Robertson; Edward Dudley; Pankaj Vadgama; Christian Cook; Scott Drawer; Liam Kilduff
Journal:  Sports Med       Date:  2012-03-01       Impact factor: 11.136

Review 2.  Circadian clocks in the digestive system.

Authors:  Anneleen Segers; Inge Depoortere
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02-02       Impact factor: 46.802

3.  Assessing the Dim Light Melatonin Onset in Adults with Autism Spectrum Disorder and No Comorbid Intellectual Disability.

Authors:  Emma K Baker; Amanda L Richdale; Agnes Hazi; Luke A Prendergast
Journal:  J Autism Dev Disord       Date:  2017-07

4.  Characterization of signaling pathways coupled to melatonin receptors in gastrointestinal smooth muscle.

Authors:  Rashad Ahmed; Sunila Mahavadi; Othman Al-Shboul; Sayak Bhattacharya; John R Grider; Karnam S Murthy
Journal:  Regul Pept       Date:  2013-03-27

5.  Melatonin MT₁ and MT₂ receptors display different molecular pharmacologies only in the G-protein coupled state.

Authors:  Céline Legros; Séverine Devavry; Sarah Caignard; Clémence Tessier; Philippe Delagrange; Christine Ouvry; Jean A Boutin; Olivier Nosjean
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

6.  Influence of nocturnal and daytime sleep on initial orthostatic hypotension.

Authors:  N C S Lewis; H Jones; P N Ainslie; A Thompson; K Marrin; G Atkinson
Journal:  Eur J Appl Physiol       Date:  2014-10-04       Impact factor: 3.078

Review 7.  Linking Traumatic Brain Injury, Sleep Disruption and Post-Traumatic Headache: a Potential Role for Glymphatic Pathway Dysfunction.

Authors:  Juan Piantino; Miranda M Lim; Craig D Newgard; Jeffrey Iliff
Journal:  Curr Pain Headache Rep       Date:  2019-07-29

Review 8.  Hormonal protection in acute pancreatitis by ghrelin, leptin and melatonin.

Authors:  Jolanta Jaworek; Stanisław Jan Konturek
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

9.  Melatonin in the mammalian olfactory bulb.

Authors:  J T Corthell; J Olcese; P Q Trombley
Journal:  Neuroscience       Date:  2013-12-21       Impact factor: 3.590

10.  Twice daily melatonin peaks in Siberian but not Syrian hamsters under 24 h light:dark:light:dark cycles.

Authors:  Evan E Raiewski; Jeffrey A Elliott; Jennifer A Evans; Gena L Glickman; Michael R Gorman
Journal:  Chronobiol Int       Date:  2012-09-24       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.